Louise Rosengaard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Louise Rosengaard has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Anne Suhr Thykjær
Department of Clinical Research University of Southern Denmark Odense Denmark
2 shared publications - Caroline Schmidt Laugesen
Department of Ophthalmology, Zealand University Hospital Roskilde, Roskilde, Denmark
2 shared publications - Frederik Nørregaard Pedersen
Department of Ophthalmology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark
2 shared publications - Jakob Grauslund
Department of Ophthalmology Odense University Hospital Odense Denmark
2 shared publications - Javad Hajari
Department of Ophthalmology, Rigshospitalet, Glostrup, Denmark
2 shared publications - Jens Andresen
Organization of Danish Practicing Ophthalmologists, Copenhagen, Denmark
2 shared publications
Latest Publications
- Open Access
- 26 July 2024
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 38 (9) , 108830
Association of continuous subcutaneous insulin therapy and diabetic retinopathy in type 1 diabetes: A national cohort study
- 26 July 2024
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 38 (9) , 108830
Open AccessAssociation of continuous subcutaneous insulin therapy and diabetic retinopathy in type 1 diabetes: A national cohort study
- Open Access
- 8 July 2023
- Published by Springer Nature in Acta Diabetologica
- Vol. 60 (11) , 1531-1539
Bariatric surgery in individuals with type 2 diabetes is not associated with short or long-term risk of diabetic retinopathy progression: results from a nationwide cohort study
Aims: Bariatric surgery is used to induce weight loss and glycemic stability in type 2 diabetes (T2D). It has been a concern that this may lead to early worsening of diabetic retinopathy (DR) due to a rapid decline in HbA1c. In this study, we evaluated the risk of short and long-term DR development and need for ocular intervention in an entire nation of individuals with T2D undergoing bariatric surgery. Methods: The study comprised a national, register-based cohort of individuals with T2D screened for DR. Cases were matched by age, sex and DR level at the date of surgery (index date) with non-bariatric controls. We extracted information on DR levels, in- and outpatient treatments, pharmaceutical prescriptions and laboratory values. We evaluated worsening of DR (incident and progressive DR) at follow-up (6 and 36 months). Results: Amongst 238,967 individuals with T2D, who attended diabetic eye screening, we identified 553 that underwent bariatric surgery (0.2%) and 2677 non-bariatric controls. Median age was 49 years, and 63% were female. Cases had more comorbidities, lower HbA1c as well as more frequent use of glucose-lowering and antihypertensive medication than controls at index date. In a fully adjusted logistic regression model, the risk of DR worsening for cases was not significantly different compared to controls, neither short-term (OR 0.41 [CI 95% 0.13; 1.33], p = 0.14) nor long-term (OR 0.64 [CI 95% 0.33; 1.24], p = 0.18). Conclusions: In this nationwide study, bariatric surgery did not associate with increased risk of short- or long-term DR worsening.
- 8 July 2023
- Published by Springer Nature in Acta Diabetologica
- Vol. 60 (11) , 1531-1539
Open AccessBariatric surgery in individuals with type 2 diabetes is not associated with short or long-term risk of diabetic retinopathy progression: results from a nationwide cohort study
Aims: Bariatric surgery is used to induce weight loss and glycemic stability in type 2 diabetes (T2D). It has been a concern that this may lead to early worsening of diabetic retinopathy (DR) due to a rapid decline in HbA1c. In this study, we evaluated the risk of short and long-term DR development and need for ocular intervention in an entire nation of individuals with T2D undergoing bariatric surgery. Methods: The study comprised a national, register-based cohort of individuals with T2D screened for DR. Cases were matched by age, sex and DR level at the date of surgery (index date) with non-bariatric controls. We extracted information on DR levels, in- and outpatient treatments, pharmaceutical prescriptions and laboratory values. We evaluated worsening of DR (incident and progressive DR) at follow-up (6 and 36 months). Results: Amongst 238,967 individuals with T2D, who attended diabetic eye screening, we identified 553 that underwent bariatric surgery (0.2%) and 2677 non-bariatric controls. Median age was 49 years, and 63% were female. Cases had more comorbidities, lower HbA1c as well as more frequent use of glucose-lowering and antihypertensive medication than controls at index date. In a fully adjusted logistic regression model, the risk of DR worsening for cases was not significantly different compared to controls, neither short-term (OR 0.41 [CI 95% 0.13; 1.33], p = 0.14) nor long-term (OR 0.64 [CI 95% 0.33; 1.24], p = 0.18). Conclusions: In this nationwide study, bariatric surgery did not associate with increased risk of short- or long-term DR worsening.